Nifty
:
11196.50
Sensex
:
37892.36
101.25 (0.91%)
204.45 (0.54%)
Nifty
Sensex
:
:
11196.50
37892.36
101.25 (0.91%)
204.45 (0.54%)

Laurus Labs Ltd.

Pharmaceuticals & Drugs - API

Rating :
75/99

BSE: 540222 | NSE: LAURUSLABS

NSE BSE
1010.00
04-Aug-2020
  • Open
  • High
  • Low
  • Previous Close
  •  1011.00
  •  1023.85
  •  952.00
  •  1006.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4886098
  •  48300.26
  •  1075.15
  •  295.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10,840.50
  • 26.31
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 11,895.63
  • 0.25%
  • 5.59

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.13%
  • 8.03%
  • 19.42%
  • FII
  • DII
  • Others
  • 16.06%
  • 7.13%
  • 17.23%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 9.76
  • 11.26

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 9.28
  • 6.43

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 13.73
  • 15.05

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 30.21

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.05

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 12.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
974.32
550.57
76.97%
839.14
635.16
32.11%
729.59
529.46
37.80%
712.42
588.28
21.10%
Expenses
696.00
467.31
48.94%
647.37
523.17
23.74%
581.42
441.74
31.62%
574.62
512.56
12.11%
EBITDA
278.32
83.26
234.28%
191.77
111.99
71.24%
148.17
87.71
68.93%
137.81
75.73
81.98%
EBIDTM
28.57%
15.12%
22.85%
17.63%
20.31%
16.57%
19.34%
12.87%
Other Income
7.09
4.50
57.56%
1.68
1.62
3.70%
1.92
1.42
35.21%
1.36
10.53
-87.08%
Interest
15.14
22.53
-32.80%
20.66
17.57
17.59%
20.83
23.65
-11.92%
25.57
24.64
3.77%
Depreciation
48.80
45.84
6.46%
46.05
43.47
5.94%
47.55
42.71
11.33%
47.83
39.82
20.12%
PBT
221.47
19.39
1,042.19%
126.74
52.57
141.09%
81.71
22.77
258.85%
65.77
21.79
201.84%
Tax
49.69
4.29
1,058.28%
16.59
9.39
76.68%
8.24
4.95
66.46%
9.22
5.58
65.23%
PAT
171.78
15.09
1,038.37%
110.15
43.18
155.09%
73.47
17.82
312.29%
56.55
16.21
248.86%
PATM
17.63%
2.74%
13.13%
6.80%
10.07%
3.37%
7.94%
2.76%
EPS
16.07
1.41
1,039.72%
10.30
4.04
154.95%
6.87
1.67
311.38%
5.29
1.52
248.03%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
3,255.47
2,831.72
2,291.92
2,056.17
1,904.65
1,777.58
1,326.59
1,159.72
Net Sales Growth
41.33%
23.55%
11.47%
7.96%
7.15%
34.00%
14.39%
 
Cost Of Goods Sold
1,584.90
1,382.89
1,224.80
1,056.02
989.29
1,000.15
821.27
720.43
Gross Profit
1,670.57
1,448.84
1,067.12
1,000.15
915.36
777.43
505.32
439.29
GP Margin
51.32%
51.16%
46.56%
48.64%
48.06%
43.74%
38.09%
37.88%
Total Expenditure
2,499.41
2,267.17
1,935.93
1,642.85
1,497.01
1,415.38
1,131.46
956.09
Power & Fuel Cost
-
136.77
109.37
94.21
66.27
57.95
49.86
35.03
% Of Sales
-
4.83%
4.77%
4.58%
3.48%
3.26%
3.76%
3.02%
Employee Cost
-
320.77
276.33
238.14
204.73
175.46
131.38
103.25
% Of Sales
-
11.33%
12.06%
11.58%
10.75%
9.87%
9.90%
8.90%
Manufacturing Exp.
-
239.50
178.96
150.78
139.47
106.97
80.61
47.96
% Of Sales
-
8.46%
7.81%
7.33%
7.32%
6.02%
6.08%
4.14%
General & Admin Exp.
-
114.23
97.48
73.17
65.42
49.09
28.39
27.30
% Of Sales
-
4.03%
4.25%
3.56%
3.43%
2.76%
2.14%
2.35%
Selling & Distn. Exp.
-
61.53
31.96
24.09
22.65
16.49
12.46
12.54
% Of Sales
-
2.17%
1.39%
1.17%
1.19%
0.93%
0.94%
1.08%
Miscellaneous Exp.
-
11.49
17.03
6.44
9.18
9.27
7.49
9.58
% Of Sales
-
0.41%
0.74%
0.31%
0.48%
0.52%
0.56%
0.83%
EBITDA
756.07
564.55
355.99
413.32
407.64
362.20
195.13
203.63
EBITDA Margin
23.22%
19.94%
15.53%
20.10%
21.40%
20.38%
14.71%
17.56%
Other Income
12.05
5.92
16.15
29.19
33.44
4.36
34.07
8.82
Interest
82.20
89.59
88.19
79.64
99.90
111.11
101.11
58.71
Depreciation
190.23
187.27
164.19
125.45
105.98
86.41
61.53
32.88
PBT
495.69
293.61
119.75
237.42
235.19
169.04
66.57
120.86
Tax
83.74
38.34
25.99
69.81
43.86
34.90
-1.55
23.64
Tax Rate
16.89%
13.06%
21.70%
29.40%
18.65%
20.65%
-2.33%
19.56%
PAT
411.95
255.27
93.76
167.61
191.33
134.14
68.12
97.22
PAT before Minority Interest
411.95
255.27
93.76
167.61
191.33
134.14
68.12
97.22
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
12.65%
9.01%
4.09%
8.15%
10.05%
7.55%
5.13%
8.38%
PAT Growth
346.32%
172.26%
-44.06%
-12.40%
42.63%
96.92%
-29.93%
 
EPS
38.54
23.88
8.77
15.68
17.90
12.55
6.37
9.09

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
1,769.78
1,558.41
1,482.64
1,330.45
856.80
722.10
358.42
Share Capital
106.91
106.44
106.03
105.76
82.38
82.13
77.84
Total Reserves
1,658.24
1,446.60
1,370.75
1,218.84
771.47
637.03
277.22
Non-Current Liabilities
214.24
295.49
174.30
132.34
428.11
363.73
203.92
Secured Loans
165.02
258.71
141.66
124.56
353.61
303.68
188.17
Unsecured Loans
0.00
0.00
0.00
0.00
106.13
0.00
0.00
Long Term Provisions
45.85
30.05
20.84
14.59
6.77
5.13
3.93
Current Liabilities
1,692.37
1,423.90
1,306.89
1,120.75
883.75
802.49
710.87
Trade Payables
615.61
488.31
312.33
263.10
247.61
230.81
227.47
Other Current Liabilities
261.47
244.50
231.26
199.11
141.05
133.34
164.25
Short Term Borrowings
790.51
684.21
758.52
644.17
481.42
431.63
312.18
Short Term Provisions
24.77
6.89
4.78
14.37
13.66
6.70
6.97
Total Liabilities
3,676.39
3,277.80
2,963.83
2,583.54
2,168.66
1,888.32
1,273.21
Net Block
1,726.34
1,629.07
1,480.80
1,229.93
1,021.03
801.01
499.27
Gross Block
2,385.73
2,105.42
1,793.75
1,418.58
1,106.33
986.17
623.32
Accumulated Depreciation
659.39
476.35
312.95
188.65
85.30
185.16
124.04
Non Current Assets
1,864.33
1,814.84
1,716.23
1,443.71
1,165.92
1,024.41
696.70
Capital Work in Progress
67.18
109.63
163.18
143.26
69.60
109.67
116.10
Non Current Investment
3.40
3.40
3.40
3.40
7.04
7.45
0.00
Long Term Loans & Adv.
40.80
25.58
29.36
25.95
29.22
93.94
68.50
Other Non Current Assets
26.61
47.16
39.50
41.17
39.03
12.34
12.82
Current Assets
1,812.06
1,462.96
1,247.59
1,139.82
1,002.73
862.27
574.81
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
905.22
681.94
584.78
509.05
487.09
475.50
328.10
Sundry Debtors
791.42
709.94
570.59
567.61
444.86
285.07
194.88
Cash & Bank
1.74
3.02
3.06
4.09
28.77
58.88
23.20
Other Current Assets
113.68
32.84
30.53
34.07
42.00
42.82
28.64
Short Term Loans & Adv.
61.91
35.22
58.63
25.01
23.86
22.75
19.80
Net Current Assets
119.69
39.05
-59.30
19.07
118.98
59.78
-136.06
Total Assets
3,676.39
3,277.80
2,963.82
2,583.53
2,168.65
1,888.32
1,273.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
347.41
297.66
342.49
331.99
181.97
-64.71
121.23
PBT
293.61
119.75
237.42
235.19
169.04
66.57
120.86
Adjustment
293.21
255.27
216.47
199.38
200.57
136.26
83.06
Changes in Working Capital
-199.76
-52.04
-49.48
-52.45
-154.37
-250.72
-59.27
Cash after chg. in Working capital
387.06
322.99
404.41
382.12
215.23
-47.89
144.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-39.64
-25.32
-61.91
-50.13
-33.26
-16.82
-23.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-221.12
-252.88
-384.15
-288.67
-312.20
-396.95
-311.82
Net Fixed Assets
-234.28
-254.84
-394.43
-354.15
-76.75
-353.86
Net Investments
0.00
-6.57
-1.22
-24.40
-7.01
-18.65
Others
13.16
8.53
11.50
89.88
-228.44
-24.44
Cash from Financing Activity
-127.66
-44.77
42.24
-53.61
103.32
486.08
203.03
Net Cash Inflow / Outflow
-1.37
0.02
0.59
-10.30
-26.91
24.42
12.44
Opening Cash & Equivalents
2.97
3.00
2.42
12.81
39.53
15.11
2.67
Closing Cash & Equivalent
1.69
2.97
3.00
2.42
12.81
39.53
15.11

Financial Ratios

Standalone /

Consolidated
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
165.10
145.91
139.28
125.25
499.30
419.61
189.14
ROA
7.34%
3.00%
6.04%
8.05%
6.61%
4.31%
7.64%
ROE
15.39%
6.19%
11.97%
18.12%
18.65%
14.47%
33.42%
ROCE
14.14%
8.22%
13.68%
16.52%
16.35%
13.74%
19.96%
Fixed Asset Turnover
1.26
1.18
1.29
1.53
1.73
1.66
1.87
Receivable days
96.76
101.97
100.40
95.66
73.56
65.47
61.02
Inventory Days
102.29
100.87
96.48
94.12
97.00
109.61
102.73
Payable days
80.46
72.80
61.13
59.14
58.52
69.29
86.77
Cash Conversion Cycle
118.59
130.03
135.75
130.64
112.05
105.79
76.98
Total Debt/Equity
0.60
0.67
0.66
0.64
1.20
1.14
1.54
Interest Cover
4.28
2.36
3.98
3.35
2.52
1.66
3.06

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


  • Laurus Labs gets USFDA’s nod for ANDAs TLE 400, TLE 600 tablets
    19th May 2020, 12:04 PM

    These approvals enables Laurus Labs to launch both the products in several LMIC markets

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.